Sign in
Taking people in United StatesNo phase

Helps young people with sickle cell disease join treatment decisions

Tests a decision-making toolkit with teens and young adults who have sickle cell disease.

Key facts

Who runs it
Nemours Children's Clinic
Where
Wilmington, United StatesSee the site
Trial code
Registry title
Empowering Adolescents and Young Adults With Sickle Cell Disease as Partners in Treatment Decision Making (EMPOWER-AYA)
Status
Recruiting
People taking part
68 people, planned
Started
26 Nov 2024
Expected to end
30 Jun 2027
Type of study
Interventional, 2 groups
Treatments tested
  • SCD Shared Decision-Making Toolkit for AYAs - including VR
  • SCD Shared Decision-Making Toolkit for AYAs - without VR
Record updated
16 June 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for teenagers and young adults with sickle cell disease who are candidates for disease-modifying therapy, plus their caregivers and Nemours sickle cell care providers.

Age
Patients 15 to 25 years old.
Sex
All sexes can join.
Disease stage
Sickle cell disease, judged by their provider to be a candidate for starting one or more disease-modifying therapies.
Earlier treatment
Must be treated at Nemours. Must not have taken part before in usability testing of the intervention.

Main reasons for not taking part

  • Took part before in usability testing of the intervention
  • History of seizures
  • Medical condition or thinking ability that stops them completing interviews
  • No legal guardian available to give consent (patients under 18 years)
  • Providers still in training

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Patients diagnosed with SCD ages 15-25 years receiving treatment at Nemours and their caregivers will be included. Patients must be deemed candidates for initiation of one or more disease-modifying therapies by their SCD healthcare provider
  • Nemours SCD healthcare providers will also be included
  • English language fluency is a requirement for all participants

Who cannot take part

  • Patients/ caregivers who previously participated in usability testing of the intervention will be excluded
  • Patients will also be excluded if they have history of seizures, if their medical status or cognitive functioning preclude completion of interviews, or if no legal guardian is available to provide consent (for patients < 18 years)
  • Providers still completing training will be excluded

Where in United States

  • Nemours Children's Hospital DelawareWilmington, United StatesContact: Clinical Research CoordinatorTaking people

About the trial

What the trial wants to find out

This study will evaluate the acceptability, feasibility, and preliminary efficacy of a shared decision making intervention for adolescents and young adults (AYAs) with sickle cell disease (SCD). 60 AYAs with SCD ages 15-25 and their caregivers and 8 SCD providers will participate in the pilot pragmatic trial. AYAs, caregivers, and providers will be recruited from Nemours Children's Hospital, Delaware (NCH-DE), Nemours Children's Hospital in Orlando, FL (NCH-ORL), and Nemours Children's Health at Wolfson Children's Hospital in Jacksonville, FL (NCH-JAX). NCH-DE participants (n=30) will receive the SDM intervention including a virtual reality patient health education component, whereas NCH-ORL and NCH-JAX participants (n=30) will receive the SDM intervention with standard patient education materials (print, video). SCD providers will be trained to use the toolkit components and will introduce decision aids during an outpatient clinic visit for AYAs who are candidates for one or more disease-modifying therapies.

The 2 groups in the trial

  • Shared Decision Making Toolkit including VRTreatment being tested

    Treatment: SCD Shared Decision-Making Toolkit for AYAs - including VR

  • Shared Decision Making Toolkit without VRTreatment being tested

    Treatment: SCD Shared Decision-Making Toolkit for AYAs - without VR

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Empowering Adolescents and Young Adults With Sickle Cell Disease as Partners in Treatment Decision Making (EMPOWER-AYA)
Plain-language title
Helps young people with sickle cell disease join treatment decisionsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
16 June 2026